News and Trends 3 Oct 2022
Incyte to acquire Medicxi-backed Villaris Therapeutics to tackle vitiligo
Incyte has entered into an agreement to acquire Villaris Therapeutics, an asset-centric biopharmaceutical company seeded by Medicxi and focused on…